9th edition

Format
HYBRID

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG, FR

December 8th, 2025

ONLINE MEETINGS

December 2nd & 3rd, 2025

IN-PERSON | STRASBOURG, FR

December 8th, 2025

ONLINE MEETINGS

2025 Speakers

We are seeking for speakers to share their experience, expertise, opinions and best practices in MedFIT conferences.
If you are interested, please contact Eline Delcroix.

Learn more about MedFIT 2025 speakers

More than 50 international experts from academia, MedTech, Diagnostic and Digital Health industries and early stage investment will explore hands-on approaches to technology transfer and open innovation sharing their experience and knowledge with the following objectives: to create new partnerships, to source innovative and competitive R&D projects, to secure funding and to facilitate market access in the field of MedTech, Diagnostic and Digital Health.

 
Hicham Najem

Hicham Najem

Fundraising specialist
BelgiumEIT Digital

Hicham Najem is fundraising specialist for EIT Digital. He has over 25 years’ experience in asset management and alternative investment strategies. He successfully raised and managed €1.2bn in market neutral quantitative equity and Global Macro portfolios at SAMCo (Shell Asset Management Co), Brevan Howard Asset Management, Tactical Global Management, and HSBC UK. Before that, he worked for the Abu Dhabi Investment Authority as a quantitative analyst. More recently, he was Managing Partner at ARADII Capital , a multi-strategy investment platform, where he oversaw fundraising and business development.

Hicham has an MBA from INSEAD and an Engineering degree from the Catholic University of Louvain (Belgium).

Hicham Najem

Fundraising specialist
BelgiumEIT Digital
Werner Lanthaler

Werner Lanthaler

CEO
AustriaWLan Holding

Dr. Werner Lanthaler is the founder and CEO of Wlanholding, an investment company focused on driving innovations and sustainable growth in cutting-edge technologies. With over 20 years of management experience in the biotech and pharmaceutical sectors, Dr. Lanthaler supports visionary entrepreneurs in transforming innovative business ideas into scalable, successful organizations. As CEO of Evotec SE, he led the company through significant global growth. Prior to that, as CFO of Intercell AG, he was instrumental in establishing Austria’s first Biotech IPO and several product approvals. Dr. Lanthaler brings an extensive network, top class expertise in due diligence and a hands-on approach to building all aspects of a business.

He is the chairman in leading high-tech companies, including Fair Journey Biologics (Portugal), HAL Allergy (Netherlands), aTenstion.life (Austria), OncoDesignServices (France), and Proxygen (Austria).

His career is further supported by a strong academic background, including a PhD in Business Administration and an MPA from Havard Universit.

Recent key investments of Wlanholding include Proxygen GmbH, Cerabyte GmbH, Solgate GmbH, Planet Pure GmbH, Cyment GmbH, Pirche GmbH and Pexxes GmbH.

Werner Lanthaler

CEO
AustriaWLan Holding

Contact

Eline Delcroix